Don’t Sleep On Inspections: Experts Warn FDA Maintains Enforcement Resources

Manufacturers of medical products would be foolish to think that recent upheavals at the US FDA will result in a lack of inspections in the coming years. A panel of experts discussed the current state of inspections during a webinar hosted by the Food and Drug Law Institute.

(Shutterstock)

More from US FDA Warning Letters

More from US FDA